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Adipose tissue is a metabolically dynamic organ for the storage of ex-
cess energy, and it also serves as an endocrine organ capable of synthesiz-
ing hormones that regulate metabolic homeostasis (Scherer, 2006).
Adipose tissuebuffers energybyhyperplasia and/or hypertrophyof adipo-
cytes when increased energy storage is needed. However, overt adiposity
results in obesity. The obese condition is a risk factor for the development
ofmany disorders, particularly insulin resistance and diabetes (Smyth and
Heron, 2006). Numerous factors, including genetics, dietary metabolites,
hormones, or a variety of secretary cytokines have been documented to
regulated the adiposity and glucose metabolism, how these factors affect
adipocytes and the relative metabolism are largely unknown.
Estrogens are known to regulate fat accumulation, energy balance,
and insulin sensitivity (Chen et al., 2009; Mauvais-Jarvis et al., 2013).
Being abundantly produced in premenopausal women, these hormones
promote andmaintain the typical female-type of fat distribution charac-
terized by accumulation of adipose tissue in the subcutaneous fat depot
with only modest accumulation of intra-abdominal adipose tissue138 Yixueyuan Road, Shanghai
en access article under the CC BY-NC(Elbers et al., 1999; Enzi et al., 1986; Shi and Clegg, 2009; Toth et al.,
2001), suggesting that premenopausal women are less prone to devel-
oping insulin resistance than men of the same age (Geer and Shen,
2009; Vistisen et al., 2014). The role of estrogens in adiposity is evi-
denced by the fact that body weight increases under low estrogen con-
ditions such as menopause, ovariectomy, or the lack of a functional
aromatase gene, and can be corrected by 17β-estradiol treatment
(Gambineri et al., 2002; Jones et al., 2000; Misso et al., 2003; Takeda et
al., 2003). Similarly, the incidence of obesity and insulin resistance in
women gradually increases after menopause (Yang et al., 2010). The
regulation of adiposity and improved glucose metabolism caused by es-
trogens in adipose tissue occurs through an ERα-mediated response
(Barros and Gustafsson, 2011; Heine et al., 2000; Ohlsson et al., 2000).
ERα deﬁcientmice exhibit increased adipose tissuemass in the absence
of differences in energy intake. Some researchers reported that poly-
morphisms in the ERα gene are associated with unhealthy upper-
body obesity in middle-aged women (Deng et al., 2000; Fox et al.,
2005; Okura et al., 2003). Estrogens play a beneﬁcial role in regulating
adiposity and glucosemetabolism, however not all womenwith low es-
trogen levels become obese and develop insulin resistance. Such varia-
tion may be related to the heterogeneity of host genotype.
Bone morphogenetic protein 4 (BMP4) is one of the morphogens in-
volved invertebrate embryonic patterning andevolutionofmesodermtis-
sues (Bier and De Robertis, 2015; Hogan, 1996). Genetic variants of BMP4-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lesterol, suggesting its role inmetabolism (Tang et al., 2013). Our previous
works demonstrate that BMP4 participates in adipose tissue development
and metabolism (Huang et al., 2009; Qian et al., 2013). BMP4 induces
brown fat-like changes inwhite adipose tissue aswell as increased insulin
sensitivity inmice.Moreover, high level of BMP4 in adipose tissue leads to
both accumulation of moremetabolically active subcutaneous adipocytes,
and the reduction in the size of the visceral fat mass-an effect similar to
that induced by estrogens. Knockout of BMP4 in adipose tissue results in
increased size of adipocytes and fatmass in both subcutaneous and viscer-
al fat of adult male mice, a phenomenon not observed in female mice.
These results indicate that cross-talks between BMP4 and estrogen signal-
ing may exist in females to balance fat mass and metabolism.
Herein, we investigated whether BMP4 cross-talks with estrogen and
ERα signaling to regulate adiposity and glucose metabolism. We found
that BMP4 and estrogen/ERα were negatively regulated by each other:
the inactivation of one pathway leads to the activation of the other path-
way that can preventmice fromovert adiposity andmetabolic disorder. In
women, BMP4 levels in subcutaneous WAT signiﬁcantly increased after
menopause, and inversely correlated with BMI in postmenopausal stage.
These ﬁndings support a counterbalance between BMP4 and ERα signal-
ing in the regulation of adiposity and glucose metabolism in females.
2. Materials & Methods
2.1. Human Adipose Tissue Samples
Subcutaneous adipose tissueswere obtained frompatients underwent
surgery irrelevant to metabolic disease in Shanghai Jiaotong University
Afﬁliated Sixth and Ninth People's Hospital and Obstetrics and Gynecolo-
gy Hospital of Fudan University. This study was approved by the ethics
committees of Fudan University Institutes of Biomedical Sciences and
was in accordance with the principle of the Helsinki Declaration II. The
written informed consent was obtained from each participant.
2.2. Generation of Adipose Tissue-speciﬁc BMP4 Knockout Mice
To generate mice with an adipocyte-Speciﬁc knockout of BMP4,
Bmp4LoxP/LoxPmice (generously provided byBrigidHogan, Department
of Cell Biology, Duke University Medical Center, Durham, NC) were
crossed with mice expressing Cre recombinase under the control of the
adipocyte-speciﬁc promoter Fabp4 (Jackson Laboratory). Genotyping
was performed by PCR. Studies were performed in Fabp4-Cre-
Bmp4LoxP/LoxP mice and littermate controls lacking the LoxP sites
(Fabp4-Cre-Bmp4+/+). Mice were maintained under 12-h light/12-h
dark cycles with unlimited access to food and water. Mice were fed
with chowor anHFD (51%kcal in fat, beginning at age 6wk). Bodyweight
was monitored every week until euthanization and tissue collection. The
data shown were collected from experiments on male and female mice.
All studies were approved by the Animal Care and Use Committee of
the FudanUniversity ShanghaiMedical College and followed the National
Institute of Health guidelines on the care and use of animals.
2.3. Isolation of Preadipocytes and Adipocytes From Adipose Tissue
Adipose tissue was harvested and the SVF cells were isolated by col-
lagenase digestion (collagenase VIII; Sigma). The digested tissuewas ﬁl-
tered through a 100-μm mesh ﬁlter to remove debris and was
centrifuged. The adipocytes ﬂoated above the supernatant. The
preadipocyte-containing pellet was suspended with an ammonium
chloride lysis buffer to remove red blood cells.
2.4. Cell Culture
Primary preadipocytes were cultured in DMEM/F12 containing 10%
FBS. Multipotent stem cell line C3H10T1/2 were in DMEM containing10% FBS. Adipocyte differentiation was induced in preadipocytes cul-
tures by treating conﬂuent cells for 48 h in medium containing 10%
FBS, 0.5 mM isobutylmethylxanthine, 125 nM indomethacin, 1 μM
dexamethasone, 850 nM insulin, 1 nM T3, and 1 μM rosiglitazone.
2 days after induction, cells were switched to maintenance medium
containing 10% FBS, 850 nM insulin, 1 nM T3, and 1 μM rosiglitazone
and maintained for 2 days. At day 5, the medium was replaced with
DMEM (phenol free) containing 10% charcoal stripped FBS (Gibco),
and the cells were grown in such a medium for another 2 days.
After 6 days of differentiation induction, cells were incubated with
or without 17β-estradiol (Sigma-Aldrich)for the indicated time
periods. 17β-estradiol was dissolved in 0.1% ethanol and sterile
medium.
2.5. Ovariectomy
At 2 month of age, female mice were matched for body composition
and underwent sham operation or bilateral OVX. Anesthesia was per-
formed with an i.p. injection of chloral hydrate (0.04 ml/10 g of body
weight). Mice were bilaterally ovariectomized through a single dorsal
midline incision across the lumbar region, making both ovaries accessi-
ble. The ovary-attached fat padwas gently grasped to lift and exteriorize
the ovary. Subsequently, the periovarian sac was peeled back over the
surface of the ovary, allowing removal of the whole ovary. Both ovaries
of the ovariectomized groupmicewere removed,whereas ovaries of the
sham-operated group were left in situ.
2.6. Glucose and Insulin Tolerance Tests
To test glucose tolerance, mice were injected i.p. with D-glucose
(2 mg/g body weight) after an overnight fast, and tail blood glucose
levels were monitored. To test insulin tolerance, mice fed ad libitum
were injected i.p. with human insulin (Eli Lilly) (0.75 mU/g body
weight) around 2:00 PM, and tail blood glucose levels were
monitored.
2.7. Serum Analyses
Mice blood was collected by retroorbital bleeding at different ages.
Sera were then prepared and used for measurements. Serum levels of
17-estradiol were determined using an ELISA kit (Cayman Chemical,
Ann Arbor, MI).
2.8. H&E Staining and Cell Size Quantitation
Standard H&E staining was performed on 5-μm parafﬁn sections of
WAT and interscapular brown adipose tissue. Cell diameter was mea-
sured in the H&E-stained sections of three individual samples in each
group using Image J.
2.9. Antibodies and Immunoblotting
To determine the protein levels of BMP4 and ERα, adipose tissue or
cultured cells were homogenized in lysis buffer containing 2% (wt/vol)
SDS and 60 mM Tris·HCl (pH 6.8) and were subjected to electrophore-
sis. Proteins then were transferred onto PVDF membrane and
immunoblotted with speciﬁc antibodies. The anti-BMP4 antibody was
from Millipore (catalog number: MAB 1094; Dilution: 1:2000), anti-
ERαwas fromSanta Cruz Biotechnology (catalog number: SC-787; Dilu-
tion: 1:500), and anti-HSP90 was also from Santa Cruz Biotechnology
(catalog number: SC-7947; Dilution: 1:1000).
2.10. Real-time quantitative PCR
Total RNA was isolated using TRIzol reagent (Invitrogen).
PrimeScript RT Master Mix (TaKaRa) was used for ﬁrst strand cDNA
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carried out with 2× PCR Master Mix (Power SYBR Green; Applied
Biosystems, Foster City, CA) on an Applied Biosystems 7500 Real-
Time PCR System (Applied Biosystems). The primers were from
(PrimerBank http://pga.mgh.harvard.edu/primerbank/), and listed
in Supplementary Table 1.2.11. Statistical Analyses
All results are presented as means ± SEM. A 2-way, 2-tailed t-test
was used for comparisons. A difference was considered signiﬁcant at
*p b 0.05, **p b 0.01, and ***p b 0.001.Fig. 1. Adiposity and glucose metabolism of BMP4 knockout mice. (A) Growth curve of BMP4 k
pictures of mice and fat pads of BMP4 knockout (left panel) and control mice (right panel). (C, D
gonadal WAT in BMP4 knockout and control male (C) and female (D) mice. n = 8. (E) H&E sta
25 μm. (F) Quantiﬁcation of adipocyte diameter of inguinal WAT, gonadal WAT and BAT from
staining section of 3 individual mice, 5 ﬁelds per mouse, 10–15 cells per ﬁeld in each group).
and quantiﬁcation of AUG (area under curve) from BMP4 knockout and control mice. n = 6–9
quantiﬁcation of AUG from BMP4 knockout and control mice. n = 6–10. BMP4+/+: wild ty
6 months except indicated, and expressed as means ± SEM, *p b 0.05, **p b 0.01, ***p b 0.001.3. Results
3.1. Female Mice With BMP4 Knockout in Adipose Tissue Are Protected
From HFD Induced Obesity and Insulin Resistance
Our previous study showed that BMP4 knockout in adipose tissue
caused male mice to gain more body weight and fat mass (Qian et al.,
2013). By contrast, female BMP4 knockout mice did not gain more body
weight (Supplementary Fig. 1A, B) or fat mass (Supplementary Fig. 1C)
thanwild type (WT)mice fed a normal chow (NC). To determinewhether
the regulation of adipose tissue is abnormal in female BMP4 knockout
mice, animals were subjected to a high fat diet (HFD) from age 6 to
26 weeks. Male BMP4 knockout mice gained more body weight (Fig. 1A)nockout and wild type control mice on HFD from 8 to 26 weeks. n = 6. (B) Representative
) Fat index (percentage of fat pad weight to thewhole bodyweight) of inguinal WAT and
ining of inguinal WAT and gonadal WAT from BMP4 knockout and control mice. Scale bar:
BMP4 knockout and control mice. (Data were collected using Image J software from H&E
(G) Glucose concentrations during an intraperitoneal glucose tolerance test (I) (n = 8)
. (H) Glucose concentrations during an intraperitoneal insulin tolerance test (n = 7) and
pe control; BMP4−/−: BMP4 knockout. Data are collected from mice on HFD at age of
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for both inguinal and gonadal WAT than female BMP4 knockout mice
(Fig. 1A–D). The increased fatmass inmale BMP4 knockoutmice correlat-
ed with larger size of adipocytes and more lipid accumulation within
adipocytes (Fig. 1E, F). Notably, even with the challenge of a HFD, female
BMP4 knockout mice gained less weight and had a lower fat mass index
for both gonadal and inguinal WAT than matched WT control mice
(Fig. 1A–D). Adipocytes in WAT of BMP4 knockout female mice were
smaller than those ofWTmice (Fig. 1E, F). Therewasnomarkeddifference
in the appearance (Supplementary Fig. 1D) and fat index (Supplementary
Fig. 1D) of BAT between female BMP4 knockout mice and control mice.
We concluded that female mice with disrupted expression of BMP4 in
adipose tissue were protected from weight gain and fat accumulation
upon HFD challenge.
Given that overt fat accumulation increases the risk for insulin resis-
tance and type 2 diabetes in both humans and mice (Smyth and Heron,
2006), we investigated the ability of glucose disposal in mice by
performing glucose tolerance tests (GTT) and insulin tolerance tests
(ITT). When challenged with an intraperitoneal glucose or insulin load,Fig. 2. Enhanced ERα signaling inWAT of BMP4 knockout femalemice. (A) Serum 17β-estradio
WAT for expression of ERα from female BMP4 knockout and controlmice onHFD at age of 6mon
tissue from BMP4 knockout and control femalemice onHFD at age of 6months. Relative grey in
ofWAT for expression of ERα target genes GPX3, LXRα and LXRβ from6months oldmice onHF
mice per group,weigh eachweek for 5weeks. (F)Whole-body oxygen consumption rate (VO2)
measured in metabolic cage, n = 8. (G) RT-qPCR analysis of WAT for expression of genes of β o
Data are expressed as means ± SEM, *p b 0.05, **p b 0.01, ***p b 0.001. BMP4+/+: wild typefemale BMP4 knockout mice suffered less impairment of glucose or insu-
lin intolerance than WT control mice, whereas the male BMP4 knockout
mice became more glucose and insulin tolerant (Fig. 1G, H). Female
BMP4 knockout mice were also protected from fatty liver as shown by
H&E staining of liver slides (Supplementary Fig. 2A), and from inﬂamma-
tion in adipose tissue as indicated by the expression of relative genes
(Supplementary Fig. 2B). These results suggested that effects of BMP4
onWAT related to adiposity and glucosemetabolism is gender dependent.
3.2. ERα Signaling Is Enhanced in BMP4 Knockout WAT of Female Mice
Because estrogens and activation of ERα play a predominant role in
regulating adiposity and insulin sensitivity, the observed dimorphism
between male and female mice may involve differential estrogens
and/or ERα signaling. The level of serum estradiol and ERα in WAT in
six months old mice were examined with enzyme-linked immunosor-
bent assay (Elisa) and Western blot, respectively. Down-regulation of
BMP4 expression in adipose tissue by genetic knockout had no effect
on serum levels of 17β-estradiol (Fig. 2A). The mRNA level of ERαwasl level showed by Elisa in BMP4 knockout and control mice. n= 4. (B) RT-qPCR analysis of
ths. n=5. (C)RepresentativeWestern blotting analysis of ERα expression level in adipose
tensity of the bandwas quantitated using Image J software. n= 6–7. (D) RT-qPCR analysis
D. n=6. (E) Daily food intake of control and knockout femalemicemaintained on aHFD, 8
of control and knockout femalemiceof 6monthsduring a 12-hour dark/12-hour light cycle
xidation from female BMP4 knockout and control mice on HFD at age of 6 months, n = 8.
control; BMP4−/−: BMP4 knockout.
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tein level of ERα (Fig. 2C) increased in both inguinal and gonadal WAT
in female BMP4 knockout mice as shown byWestern blot. The reported
targets of ERα - glutathioneperoxidase 3 (GPX3), Liver X receptorα and
β (LXRα and LXRβ) were also determined. In inguinal WAT, GPX3 was
elevated in female knockout mice, whereas LXRα and LXRβ were not
changed. In gonadal WAT, all of the three targets were elevated (Fig.
2D). Unlike the results found for females, BMP4 knockout in male adi-
pose tissue led to lower levels of ERα (Supplementary Fig. 3A), indicat-
ing that effect of BMP4 on ERαmay depend on the level of estrogens
(Supplementary Fig. 3B).
Regarding that ERα activity reduces fat accumulation, the leanness
of female BMP4 knockout mice may be attributed to the elevation of
ERα signaling. To determinewhether the elevated ERα signaling altered
energy balance, we calculated the energy intake and expenditure. There
was no signiﬁcant difference in food intake between female knockout
and control mice (Fig. 2E). Oxygen consumption rates of BMP4 knock-
out mice were substantially increased relative to those of control mice
(Fig. 2F). Consistent with this elevated energy expenditure, expression
of genes for β oxidation-Acox1 (acyl-Coenzyme A oxidase 1), VLCAD
(acyl-Coenzyme A dehydrogenase, very long chain), MCAD (acyl-Coen-
zyme A dehydrogenase, medium chain), and CPT1b (carnitine
palmitoyltransferase 1b) - in both inguinal and gonadal WAT increased
substantially in the BMP4 knockout mice compared to those in control
(Fig. 3G).Fig. 3. BMP4 knockout Increased protein stability of ERα in adipocytes. (A) Preadipocytes iso
adipogenesis. Differentiated adipocytes were maintained for more 12 h in presence of 100 nM
of ERα expression level in differentiated adipocyte indicated in A. (C) Differentiated multip
different concentration in presence of 100 nM estradiol for 12 h, and the level of ERα was exa
expressing ERα-FLAG were induced to differentiation and at day 4 and cells were infected w
with anti-Flag antibody by Western blot 48 h after infection. (E) Differentiated adipocytes fr
incubated with cycloheximide (20 μM) for the indicated times and ERαwas examined by Wes
incubated with combination of 20 ng/ml BMP4 and 25 μM MG132 for 8 h. ERα was exami
individual experiments was quantitated using Image J software.3.3. BMP4 Knockout Increased Protein Stability of ERα in Adipocytes
The BMP4 inhibition of ERα in female mice was further veriﬁed in
cultured adipocytes. Preadipocytes from inguinal WAT of female WT
and BMP4 knockout mice were isolated, cultured and induced to differ-
entiate. About 90% of cells were differentiated into adipocytes. BMP4
knockout (Fig. 3A) was conﬁrmed by real-time PCR. Cultured mature
adipocytes were maintained for 12 h more in the medium with
100 nM estradiol, and the level of ERα was determined by Western
blot. We found that the amount of ERα protein increased in cultured
BMP4 knockout adipocytes (Fig. 3B), consistentwith the change in vivo.
To study howBMP4 regulates ERα, multipotent C3H10T1/2 cells sta-
bly expressing FLAG-tagged ERα were induced to differentiate. In this
cell model, BMP4 treatment decreased ERα level in a dose dependent
manner (Fig. 3C), and knockdown of BMP4 with short hairpin RNA in-
creased the level of ERα, an effect that could be reversed by BMP4 treat-
ment (Fig. 3D). Moreover, the regulation of ERα by BMP4 was
dependent upon the level of estrogens. Only at high concentrations of
estradiol (100 nM), BMP4 showed obvious inhibitory effect on ERα pro-
tein level (Supplementary Fig. 3B).
It is reasonable to believe that BMP4 promotes the degradation of
ERα protein, since the mRNA level of ERα in BMP4 knockout adipocyte
was not much different from that in wild-type adipocyte. The differen-
tiated adipocytes from C3H10T1/2 cells treated with or without of
BMP4 were incubated with cycloheximide (20 μM) for different timeslated from adipose tissue of female BMP4 knockout and control mice were stimulated to
estradiol, and RT-qPCR analysis of BMP4 expression level. (B) Western blotting analysis
otent C3H10T1/2 cells stably expressing FLAG tagged ERα were treated with BMP4 at
mined with anti-Flag antibody by Western blot. (D) Multipotent C3H10T1/2 cells stably
ith adenovirus expressing BMP4 shRNA and control Lac Z sh, the of ERα was examined
om C3H10T1/2 cells stably expressing ERα-FLAG treated with or without of BMP4 were
tern blot. (F) Differentiated C3H10T1/2 cells pretreated with cycloheximide (20 μM) and
ned by Western blot. For Western blot, relative grey intensity of the band from three
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icantly decreased the half-life of ERα (Fig. 3E). The inhibition of
proteasomal degradation with MG132 (25 μM) completely abolished
the BMP4 inhibition of ERα protein (Fig. 3F). These data support the no-
tion that BMP4 regulates ERα signaling mainly through the regulation
of the stability of ERα proteins.
3.4. Decreased Level of Estrogens Up-regulates BMP4 Expression in Adipose
Tissue
Above results showed that in adult female BMP4 knockout mice
with high levels of estrogens, overt adiposity and impaired insulin sen-
sitivity may be prevented by up-regulation of ERα signaling. However,
endogenous estrogen levels decrease as female mice age. We found
that BMP4 knockout did not obviously increase ERα level in aged mice
(Supplementary Fig. 4A), which is consistence with the result that
BMP4 regulation of ERα depends on the level of estrogen (Supplemen-
tary Fig. 3B). Moreover, we examined the expression of the target genes
downstream of ERα and found that the expression of GPX3 decreasedFig. 4.Decreased level of estrogens up regulates BMP4expression in adipose tissue. (A)Western
young (6months old) and (22months old) old femalemice. (B) Relative grey intensity of the ba
of BMP4expression level in inguinal and gonadalwhite adipose tissue from femalemice at indic
(D) Serum 17β-estradiol level showed by Elisa in female mice at indicated ages. n = 4–8. (E) R
preadipocytes treated with estradiol (100 ng/ml). (data from three independent experiments)
(data from three independent experiments). (G) Relative expression level of BMP4 showed by R
+: wild type control; BMP4−/−: BMP4 knockout.by about 80 fold, that of LXRα and LXRβ also decreased by 10 fold as
compared with young mice (Supplementary Fig. 4B). The data sug-
gested the estrogen/ERα signaling was inhibited in aged mice, and
would not efﬁciently perform its beneﬁt function on adipose tissue.
To assess the effect of BMP4 knockout in aged female mice, we then
examined the regulation of BMP4 in both young and aged mice. WT
male and female mice fed NC were examined at age of six months and
22 months of age. Expression of BMP4 in WAT was determined by
Western blot. As illustrated in Fig. 4A and B, BMP4 was expressed in
both inguinal and gonadal WAT, with higher expression in young
male mice than female mice. BMP4 expression in WAT also showed
age-related differences (Fig. 4A, B). Aged male mice expressed a higher
level of BMP4 than young male mice, but this difference was not signif-
icant. However, the increase of BMP4 expression with aging was dra-
matic in female mice, and the aged female mice at the age of
22 months had much higher level of BMP4 than male mice at the
same age. Interestingly, there was an inverse correlation between
serum17β-estradiol (Fig. 4D) andBMP4 levels (Fig. 4C) inWAT from fe-
malemice at different ages, suggesting that estrogensmay play a role inblotting analysis of ERα expression level in inguinal and gonadalwhite adipose tissue from
nd showed inA quantitated using Image J software. n=3–4. (C)Western blotting analysis
ated ages. Relative grey intensity of the bandwasquantitatedusing Image J software. n=4.
T-qPCR analysis for expression of BMP4 in differentiated adipocytes from primary isolated
. (F) ERα expression level showed by RT-qPCR in adipocytes with ERα SiRNA transfection
T-qPCR in differentiated adipocytes (data from three independent experiments). BMP4+/
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effect of estrogens on BMP4 in adipocytes, we treated adipocytes differ-
entiated from primary preadipocyte with estradiol (100 ng/ml). We
found that the estradiol treatment gradually decreased BMP4 mRNA
level, which were then maintained at a relatively low level (Fig. 4E). In
contrast, knock down of ERα (Fig. 4F) increased the mRNA level of
BMP4 in the presence of estradiol (Fig. 4G). These results indicate that
estrogens indeed down-regulates BMP4 expression through ERα
signaling.
3.5. Aged BMP4-knockout Female Mice Are Prone to Developing Obesity
and Insulin Resistance
Talking advantage of the BMP4 knockout mice, in which BMP4 ex-
pression cannot be upregulated during aging (Fig. 5A), we examined
whether miss-regulation of BMP4 affects the fat accumulation in aged
female mice. We found that aged female BMP4 knockout mice
(22 months) had a higher fat index with a remarkable change in the
amount of gonadal WAT (Fig. 5B). Adipocytes enlarge as mice age, and
old BMP4 knockout mice developed even larger adipocytes than WT
mice (Fig. 5C). Accordingly, female BMP4 knockout mice displayed
more severe insulin resistance than WT mice as shown by results of
GTT (Fig. 5D) and ITT (Fig. 5E).Fig. 5. Aged BMP4-knockout female mice are prone to developing obesity and insulin resistanc
from BMP4 knockout and control mice at different ages. Relative grey intensity of the bandwas
in aged BMP4 knockout and control mice. n = 6–7. (C) H&E staining of inguinal WAT and
concentrations during an intraperitoneal glucose tolerance test and quantiﬁcation of AUG
concentrations during an intraperitoneal insulin tolerance test and quantiﬁcation of AUG fro
age different ages (Young: 6 months; Aged 22 months), and expressed as means ± SEM, *p b3.6. Ovariectomized BMP4-knockout Females Are Prone to Developing Obe-
sity and Insulin Resistance, Which Can Be Reduced by Estradiol Treatment
To further verify the role of estrogens in the regulation of BMP4 ex-
pression and its consequence effects on adipose tissue, female WT and
KO mice (2 months old) were ovariectomized (OVX) and maintained
for eight weeks to deplete ovarian steroid hormones, followed by intra-
peritoneal administration of estradiol (E2) for six weeks. The level of
ERα in white adipose tissue was ﬁrstly examined and the result of
Western blot showed that ERα in OVX mice decreased as compared to
shammice, whichwas restored after E2 administration (Supplementary
Fig. 4C). The estrogen/ERα signaling was also inhibited in OVX mice
with estrogens depleted as shown by the expression of target genes
(GPX3, LXRα and LXRβ) (Supplementary Fig. 4D).
Similar to the results found in agedmice, the removal of endogenous
estrogens led to elevated levels of BMP4 inWAT, an effect that could be
reversed by estradiol treatment (Fig. 6A). After OVX, female BMP4
knockout mice gained more body weight than WT mice (Fig. 6B), and
E2 treatment decreased body weight in both WT and knockout mice
(Fig. 6C). Although E2 treatment for 6 weeks did not reverse the body
weight of BMP4 knockout mice to a level lowered than WT mice (The
phenotype of adult mice with normal level of estrogens), the difference
between them diminished (Fig. 6C). Female OVX BMP4 knockout micee. (A) Western blotting analysis of BMP4 expression level in gonadal white adipose tissue
quantitated using Image J software. n=6. (B) Fat index of inguinalWAT and gonadalWAT
gonadal WAT from BMP4 knockout and control mice. Scale bar: 20 μm. (D) Glucose
(area under curve) from aged BMP4 knockout and control mice. n = 7. (E) Glucose
m aged BMP4 knockout and control mice. n = 6. Data are collected from mice on NC at
0.05, **p b 0.01, ***p b 0.001.
Fig. 6.Estradiol reducedobesity and insulin resistance of ovariectomized female BMP4-knockoutmice.WTandKO femalemice at age of 2monthswere ovariectomizedandmaintained for
8weeks to deplete ovarian steroid hormone, followed by ip administration of estradiol for 6weeks. (A)Western blotting analysis of BMP4 expression level inWAT. Relative grey intensity
of the bandwas quantitated using Image J software. n= 4. (B) Bodyweight of BMP4 knockout and control mice after ovariectomized. n= 4. (C) Change of bodyweight of ovariectomized
female mice during the period of estradiol administration. n = 4. (D) Glucose concentrations during an intraperitoneal glucose tolerance test (n = 8) and quantiﬁcation of AUG (area
under curve) from ovariectomized BMP4 knockout and control mice. n = 6. (E) Glucose concentrations during an intraperitoneal insulin tolerance test (n = 7) and quantiﬁcation of
AUG from ovariectomized BMP4 knockout and control mice. n = 6. (F) Glucose concentrations during an intraperitoneal glucose tolerance test (n = 8) and quantiﬁcation of AUG
(area under curve) from ovariectomized BMP4 knockout and control mice treated with estradiol. n = 6. (G) Glucose concentrations during an intraperitoneal insulin tolerance test
(n = 7) and quantiﬁcation of AUG from ovariectomized BMP4 knockout and control mice treated with estradiol. n = 6.
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mice as shown by the results of GTT (Fig. 6D) and ITT (Fig. 6E). This im-
pairmentwas also reversed by administration of exogenous estrogen E2
(Fig. 6F, G). Taken together, elevated BMP4 expression appears to com-
pensate the lack of endogenous estrogens to overcome the defect in ad-
ipose tissue under the condition of low endogenous estrogens, and the
failure of BMP4 response may lead to defects in adipose tissue and rela-
tive glucose metabolism.
3.7. The Correlation Between BMP4 Levels and Body Mass Index (BMI)
Depended Upon Estrogen Level
Our previous study showed that the level of BMP4 in human subcu-
taneousWAT from 32 participants (15males, 17 females) correlated in-
versely with BMI(Qian et al., 2013), in the present study, more female
participants were enrolled, and the females participants were grouped
into premenopause and postmenopause (N55 years old) groups. We
found thatBMP4 levels in subcutaneous WAT signiﬁcantly increased
after menopause (Fig. 7A), and BMP4 levels inversely correlated with
BMI in postmenopausal women (Fig. 7C). There was no signiﬁcant cor-
relation between BMP4 levels and BMI in premenopausal women,however, the data from individuals with BMI N30 lead the correlation
to show the similar trend (Fig. 7B).
4. Discussion
Women have more subcutaneous fat and less visceral fat than men,
and obesity and insulin resistance are less prevalent in young and mid-
dle-aged women but more prevalent in women over 60 (Yang et al.,
2010). While their lower estrogen levels have been suggested to be a
cause of the increase in obesity and insulin resistance among postmen-
opausal women, the underlying mechanism has yet to be clariﬁed. Di-
rect action of estrogens upon adipose tissue as well as indirect action
through other factors may be involved (Meyer et al., 2011). Results
from our previous study showed that BMP4 stimulates brown-like
changes in WAT and improves insulin sensitivity (Qian et al., 2013).
On the contrary, disruption of BMP4 in adipose tissue leads to obesity
and insulin resistance in male mice (Qian et al., 2013). In this study,
howeverwe found that obesity and impairments in glucosemetabolism
did not occur in female BMP4 knockout mice. When challenged with
HFD, female BMP4 knockoutmicewere protected from obesity. The dif-
ference between male and female mice in the effect of BMP4 on
Fig. 7. The correlation between BMP4 level and body mass index (BMI) dependents on activation of estrogen/ERα. (A) Real-time PCR determined the BMP4mRNA level in subcutaneous
WAT of pre and post-menopausal women. (B&C) Linear regression analysis between BMI and BMP4 mRNA level in subcutaneous adipose tissue of premenopausal and postmenopausal
women. (D) Schematic Model: Counterbalance between BMP4 and estrogen/ERα signaling in adipose tissue development and energy metabolism.
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between BMP4 and estrogen signaling.
Our results showed that BMP4 knockout enhanced ERα levels in
WAT. BMP4 is a member of the transforming growth factor β (TGF β)
superfamily. Two major signaling pathways, the SMAD (mothers
against decapentaplegic Drosophila homologue) pathway and p38
MAP kinase pathway convey most biological functions of BMP4
(Bragdon et al., 2011). Although there is no report on the regulation of
ERα by BMP4, interactions between ERα and TGFβ had been studied
in breast cancer cells (Band and Laiho, 2011; Ito et al., 2010; Stope et
al., 2010), inwhich TGFβwas shown to have anti-estrogen activity, pos-
sibly by increasing proteasome-dependent degradation of ERα (Petrel
and Brueggemeier, 2003). Considering that TGFβ and BMP4 share
some of signaling partners, BMP4 is also very likely to be implicated in
the regulation of ERα protein in adipocytes. In the present study, we
found that activation by BMP4 stimulated the degradation of ERα
through the proteasomal pathway (Fig. 3F), however the mechanism
by which BMP4 meditates proteasomal degradation of ERα in WAT re-
mains to be explored.
In young female mice, with normal levels of circulating estrogens,
ERα signaling was activated as indicated by increased transcription of
the reported ERα target genes. One of the tested genes-GPX3 plays im-
portant roles in metabolism. It was reported that the enzyme activity of
GPX3 is negatively correlated to BMI (Olusi, 2002). GPX3 mRNA level
was shown to increase in women with weight loss (Dahlman et al.,
2005). LXRα and LXRβ are also targets of ERα. However mRNA of
LXRα and LXRβ was not signiﬁcantly enhanced in subcutaneous WAT.
Because LXR genes have a complex regulation, theremight bemore fac-
tors participating in their expression. The activation of ERα signaling
resulting from the knockout of BMP4 prevented overt adiposity and in-
sulin resistance. As predicted, failure of activation of ERα due to aging
and ovariectomy in female knockout mice (Supplementary Fig. 4)yielded a phenotype similar to that of male mice. Notably, loss of estro-
gens up-regulated the BMP4 level in WAT, and estrogens suppressed
BMP4 expression through ERα signaling (Fig. 4F and G). The inhibitory
effect of estrogens on BMP4 expression was also reported in other cell
types, including cardiomyocytes (Wang et al., 2014) and submucosal
smooth muscle cells in the adult female reproductive tract
(Bhattacherjee et al., 2013).
Our results showed that BMP4 inhibited ERα signaling by increasing
the degradation of ERα, and that the expression of BMP4 itself was sup-
pressed by estrogens. This highlights the complexity of the regulatory
network for adipocyte development and glucose metabolism. The
crosstalk between BMP4 and estrogen/ ERα suggests a homeostatic bal-
ance between these two factors (Fig. 7D), with loss of either one
resulting in the activation of the other to compensate for the defect.
The level of estrogens is age-dependent in females, whereas the ex-
pression of BMP4 might be inﬂuenced by genetics and may be highly
variable among humans. It was reported that one genetic variant of
BMP4 (single nucleotide polymorphism rs8014363) was associated
with levels of triglyceride and high-density lipoprotein cholesterol
after adjusting for age, gender, and BMI in a study that involved 6822
participants (Tang et al., 2013), supporting a link between BMP4 genet-
ics and adipose tissuemetabolism. Our previous study also showed that
the level of BMP4 in human adipose tissues of about 32 participants (15
males and 17 females) correlated inversely with BMI (Qian et al., 2013).
Withmore female participants enrolled in this study, we found that the
inverse correlation was signiﬁcant among postmenopausal women
rather than premenopausal ones. Estrogens are an important sex hor-
mone in females that decreases with age and in some pathological con-
ditions, and when the regulation of BMP4 becomes dominant, which
affect the incidence of obesity (Fig. 7D). This study also suggests that
the regulation of BMP4 may offer a new opportunity of intervention in
the control of excessive obesity.
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